Everest Organics
366.35
+17.40(+4.99%)
Market Cap₹338.90 Cr
PE Ratio54.61
IndustryHealthcare
Company Performance:
1D+4.99%
1M+9.69%
6M+42.85%
1Y+174.52%
5Y+16.91%
View Company Insightsright
Latest news about Everest Organics
Everest Organics Board Approves Key Director Re-appointments and New Company Secretary Aug 05, 2025
Everest Organics Limited has re-appointed Dr. Srikakarlapudi Sirisha as Managing Director and Mr. Srikakarlapudi Harikrishna as Whole-time Director, both for three-year terms starting 2025, subject to shareholder approval. Ms. Shweta Singh has been appointed as the new Company Secretary and Compliance Officer. The company reported a significant financial turnaround in Q1 FY2026, with revenue increasing by 65.84% to ₹5,381.32 lakhs and a profit after tax of ₹140.52 lakhs, compared to a loss in the same quarter last year.
Everest Organics Reports Profit Turnaround, Approves Key Management Reappointments Aug 05, 2025
Everest Organics Secures Korean Drug Master File Approval for Rabeprazole Sodium API Feb 18, 2025